TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
127 hedge funds and large institutions have $307M invested in Tvardi Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
+13
Holders Change %
+11.4%
% of All Funds
3.17%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
31
Increased
46
Reduced
34
Closed
17
Calls
$20.6M
Puts
$36.2M
Net Calls
-$15.6M
Net Calls Change
-$11.8M
Top Buyers
1 |
State Street
Boston,
Massachusetts
|
+$43.6M |
2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$8.08M |
3 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$4M |
4 |
BlackRock
New York
|
+$3.61M |
5 |
Morgan Stanley
New York
|
+$3M |